FDA approves Susvimo for diabetic macular edema
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...
dvm3606d
Making ophthalmic exams easier for general practitioners
Ron Ofri, DVM, PhD, DECVO, provided veterinary professionals at the Veterinary Meeting & Expo conference ways to make ...
U.S. News & World Report7d
FDA Approves Susvimo for Diabetic Macular Edema
The most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular pressure, while the most common nonocular side effects included ...
ophthalmologytimes16d
Researchers identify 'Triangle sign' as key diagnostic marker in ocular pathologies
The “Triangle sign” seen on ultrasound is a “distinctive and reliable” ultrasound feature for differentiating total choroidal ...
Medscape6d
Management of Primary Rhegmatogenous Retinal Detachment
Dr. Schwartz is assistant professor of clinical ophthalmology, Bascom Palmer Eye Institute ... Note the small amount of adjacent vitreous hemorrhage. Diagram depicting a single horseshoe retinal ...